Global Artemisinin Combination Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Artemisinin Combination Therapy market size was valued at USD 358 million in 2023 and is forecast to a readjusted size of USD 490.3 million by 2030 with a CAGR of 4.6% during review period.
Artemisinin Combination Therapy is recommended for thetreatment of P. falciparum malaria. Fast acting artemisinin-based compounds arecombined with a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether.
The Global Info Research report includes an overview of the development of the Artemisinin Combination Therapy industry chain, the market status of Hospital (Artemether+Lumefantrine, Artesunate+Amodiaquine), Clinic (Artemether+Lumefantrine, Artesunate+Amodiaquine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Artemisinin Combination Therapy.
Regionally, the report analyzes the Artemisinin Combination Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Artemisinin Combination Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Artemisinin Combination Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Artemisinin Combination Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Artemether+Lumefantrine, Artesunate+Amodiaquine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Artemisinin Combination Therapy market.
Regional Analysis: The report involves examining the Artemisinin Combination Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Artemisinin Combination Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Artemisinin Combination Therapy:
Company Analysis: Report covers individual Artemisinin Combination Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Artemisinin Combination Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Artemisinin Combination Therapy. It assesses the current state, advancements, and potential future developments in Artemisinin Combination Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Artemisinin Combination Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Artemisinin Combination Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Artemisinin Combination Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artemisinin Combination Therapy, with revenue, gross margin and global market share of Artemisinin Combination Therapy from 2019 to 2024.
Chapter 3, the Artemisinin Combination Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Artemisinin Combination Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artemisinin Combination Therapy.
Chapter 13, to describe Artemisinin Combination Therapy research findings and conclusion.
Artemisinin Combination Therapy is recommended for thetreatment of P. falciparum malaria. Fast acting artemisinin-based compounds arecombined with a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether.
The Global Info Research report includes an overview of the development of the Artemisinin Combination Therapy industry chain, the market status of Hospital (Artemether+Lumefantrine, Artesunate+Amodiaquine), Clinic (Artemether+Lumefantrine, Artesunate+Amodiaquine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Artemisinin Combination Therapy.
Regionally, the report analyzes the Artemisinin Combination Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Artemisinin Combination Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Artemisinin Combination Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Artemisinin Combination Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Artemether+Lumefantrine, Artesunate+Amodiaquine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Artemisinin Combination Therapy market.
Regional Analysis: The report involves examining the Artemisinin Combination Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Artemisinin Combination Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Artemisinin Combination Therapy:
Company Analysis: Report covers individual Artemisinin Combination Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Artemisinin Combination Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Artemisinin Combination Therapy. It assesses the current state, advancements, and potential future developments in Artemisinin Combination Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Artemisinin Combination Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Artemisinin Combination Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Artemether+Lumefantrine
- Artesunate+Amodiaquine
- Dihydroartemisinin+Piperaquine
- Artesunate+Mefloquine
- Artesunate+Sulfadoxine-Pyrimethamine
- Pyronaridine-Artesunate
- Other
- Hospital
- Clinic
- Other
- KPC Pharmaceuticals
- Shanghai Fosun Pharmaceutical Industrial Development
- Sanofi
- Desano Holdings
- Calyx Chemicals and Pharmaceuticals
- Mylan
- Novartis
- Denk Pharma
- Hovid Berhad
- Ipca Laboratories
- Cipla
- Aspen Pharmacare Holdings
- Ajanta Pharma
- Guilin Pharmaceuticals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Artemisinin Combination Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artemisinin Combination Therapy, with revenue, gross margin and global market share of Artemisinin Combination Therapy from 2019 to 2024.
Chapter 3, the Artemisinin Combination Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Artemisinin Combination Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artemisinin Combination Therapy.
Chapter 13, to describe Artemisinin Combination Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Artemisinin Combination Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artemisinin Combination Therapy by Type
1.3.1 Overview: Global Artemisinin Combination Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Artemisinin Combination Therapy Consumption Value Market Share by Type in 2023
1.3.3 Artemether+Lumefantrine
1.3.4 Artesunate+Amodiaquine
1.3.5 Dihydroartemisinin+Piperaquine
1.3.6 Artesunate+Mefloquine
1.3.7 Artesunate+Sulfadoxine-Pyrimethamine
1.3.8 Pyronaridine-Artesunate
1.3.9 Other
1.4 Global Artemisinin Combination Therapy Market by Application
1.4.1 Overview: Global Artemisinin Combination Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Artemisinin Combination Therapy Market Size & Forecast
1.6 Global Artemisinin Combination Therapy Market Size and Forecast by Region
1.6.1 Global Artemisinin Combination Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Artemisinin Combination Therapy Market Size by Region, (2019-2030)
1.6.3 North America Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 KPC Pharmaceuticals
2.1.1 KPC Pharmaceuticals Details
2.1.2 KPC Pharmaceuticals Major Business
2.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
2.1.4 KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 KPC Pharmaceuticals Recent Developments and Future Plans
2.2 Shanghai Fosun Pharmaceutical Industrial Development
2.2.1 Shanghai Fosun Pharmaceutical Industrial Development Details
2.2.2 Shanghai Fosun Pharmaceutical Industrial Development Major Business
2.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product and Solutions
2.2.4 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Artemisinin Combination Therapy Product and Solutions
2.3.4 Sanofi Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Desano Holdings
2.4.1 Desano Holdings Details
2.4.2 Desano Holdings Major Business
2.4.3 Desano Holdings Artemisinin Combination Therapy Product and Solutions
2.4.4 Desano Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Desano Holdings Recent Developments and Future Plans
2.5 Calyx Chemicals and Pharmaceuticals
2.5.1 Calyx Chemicals and Pharmaceuticals Details
2.5.2 Calyx Chemicals and Pharmaceuticals Major Business
2.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
2.5.4 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Calyx Chemicals and Pharmaceuticals Recent Developments and Future Plans
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Artemisinin Combination Therapy Product and Solutions
2.6.4 Mylan Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Mylan Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Artemisinin Combination Therapy Product and Solutions
2.7.4 Novartis Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Denk Pharma
2.8.1 Denk Pharma Details
2.8.2 Denk Pharma Major Business
2.8.3 Denk Pharma Artemisinin Combination Therapy Product and Solutions
2.8.4 Denk Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Denk Pharma Recent Developments and Future Plans
2.9 Hovid Berhad
2.9.1 Hovid Berhad Details
2.9.2 Hovid Berhad Major Business
2.9.3 Hovid Berhad Artemisinin Combination Therapy Product and Solutions
2.9.4 Hovid Berhad Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hovid Berhad Recent Developments and Future Plans
2.10 Ipca Laboratories
2.10.1 Ipca Laboratories Details
2.10.2 Ipca Laboratories Major Business
2.10.3 Ipca Laboratories Artemisinin Combination Therapy Product and Solutions
2.10.4 Ipca Laboratories Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Ipca Laboratories Recent Developments and Future Plans
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business
2.11.3 Cipla Artemisinin Combination Therapy Product and Solutions
2.11.4 Cipla Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cipla Recent Developments and Future Plans
2.12 Aspen Pharmacare Holdings
2.12.1 Aspen Pharmacare Holdings Details
2.12.2 Aspen Pharmacare Holdings Major Business
2.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product and Solutions
2.12.4 Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Aspen Pharmacare Holdings Recent Developments and Future Plans
2.13 Ajanta Pharma
2.13.1 Ajanta Pharma Details
2.13.2 Ajanta Pharma Major Business
2.13.3 Ajanta Pharma Artemisinin Combination Therapy Product and Solutions
2.13.4 Ajanta Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ajanta Pharma Recent Developments and Future Plans
2.14 Guilin Pharmaceuticals
2.14.1 Guilin Pharmaceuticals Details
2.14.2 Guilin Pharmaceuticals Major Business
2.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
2.14.4 Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Guilin Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artemisinin Combination Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Artemisinin Combination Therapy by Company Revenue
3.2.2 Top 3 Artemisinin Combination Therapy Players Market Share in 2023
3.2.3 Top 6 Artemisinin Combination Therapy Players Market Share in 2023
3.3 Artemisinin Combination Therapy Market: Overall Company Footprint Analysis
3.3.1 Artemisinin Combination Therapy Market: Region Footprint
3.3.2 Artemisinin Combination Therapy Market: Company Product Type Footprint
3.3.3 Artemisinin Combination Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artemisinin Combination Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Artemisinin Combination Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Artemisinin Combination Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
6.2 North America Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
6.3 North America Artemisinin Combination Therapy Market Size by Country
6.3.1 North America Artemisinin Combination Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
7.2 Europe Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
7.3 Europe Artemisinin Combination Therapy Market Size by Country
7.3.1 Europe Artemisinin Combination Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7.3.3 France Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Region
8.3.1 Asia-Pacific Artemisinin Combination Therapy Consumption Value by Region (2019-2030)
8.3.2 China Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.5 India Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
9.2 South America Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
9.3 South America Artemisinin Combination Therapy Market Size by Country
9.3.1 South America Artemisinin Combination Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Country
10.3.1 Middle East & Africa Artemisinin Combination Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Artemisinin Combination Therapy Market Drivers
11.2 Artemisinin Combination Therapy Market Restraints
11.3 Artemisinin Combination Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Artemisinin Combination Therapy Industry Chain
12.2 Artemisinin Combination Therapy Upstream Analysis
12.3 Artemisinin Combination Therapy Midstream Analysis
12.4 Artemisinin Combination Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Artemisinin Combination Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artemisinin Combination Therapy by Type
1.3.1 Overview: Global Artemisinin Combination Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Artemisinin Combination Therapy Consumption Value Market Share by Type in 2023
1.3.3 Artemether+Lumefantrine
1.3.4 Artesunate+Amodiaquine
1.3.5 Dihydroartemisinin+Piperaquine
1.3.6 Artesunate+Mefloquine
1.3.7 Artesunate+Sulfadoxine-Pyrimethamine
1.3.8 Pyronaridine-Artesunate
1.3.9 Other
1.4 Global Artemisinin Combination Therapy Market by Application
1.4.1 Overview: Global Artemisinin Combination Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Artemisinin Combination Therapy Market Size & Forecast
1.6 Global Artemisinin Combination Therapy Market Size and Forecast by Region
1.6.1 Global Artemisinin Combination Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Artemisinin Combination Therapy Market Size by Region, (2019-2030)
1.6.3 North America Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Artemisinin Combination Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 KPC Pharmaceuticals
2.1.1 KPC Pharmaceuticals Details
2.1.2 KPC Pharmaceuticals Major Business
2.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
2.1.4 KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 KPC Pharmaceuticals Recent Developments and Future Plans
2.2 Shanghai Fosun Pharmaceutical Industrial Development
2.2.1 Shanghai Fosun Pharmaceutical Industrial Development Details
2.2.2 Shanghai Fosun Pharmaceutical Industrial Development Major Business
2.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product and Solutions
2.2.4 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Artemisinin Combination Therapy Product and Solutions
2.3.4 Sanofi Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Desano Holdings
2.4.1 Desano Holdings Details
2.4.2 Desano Holdings Major Business
2.4.3 Desano Holdings Artemisinin Combination Therapy Product and Solutions
2.4.4 Desano Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Desano Holdings Recent Developments and Future Plans
2.5 Calyx Chemicals and Pharmaceuticals
2.5.1 Calyx Chemicals and Pharmaceuticals Details
2.5.2 Calyx Chemicals and Pharmaceuticals Major Business
2.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
2.5.4 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Calyx Chemicals and Pharmaceuticals Recent Developments and Future Plans
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Artemisinin Combination Therapy Product and Solutions
2.6.4 Mylan Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Mylan Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Artemisinin Combination Therapy Product and Solutions
2.7.4 Novartis Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Denk Pharma
2.8.1 Denk Pharma Details
2.8.2 Denk Pharma Major Business
2.8.3 Denk Pharma Artemisinin Combination Therapy Product and Solutions
2.8.4 Denk Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Denk Pharma Recent Developments and Future Plans
2.9 Hovid Berhad
2.9.1 Hovid Berhad Details
2.9.2 Hovid Berhad Major Business
2.9.3 Hovid Berhad Artemisinin Combination Therapy Product and Solutions
2.9.4 Hovid Berhad Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hovid Berhad Recent Developments and Future Plans
2.10 Ipca Laboratories
2.10.1 Ipca Laboratories Details
2.10.2 Ipca Laboratories Major Business
2.10.3 Ipca Laboratories Artemisinin Combination Therapy Product and Solutions
2.10.4 Ipca Laboratories Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Ipca Laboratories Recent Developments and Future Plans
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business
2.11.3 Cipla Artemisinin Combination Therapy Product and Solutions
2.11.4 Cipla Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cipla Recent Developments and Future Plans
2.12 Aspen Pharmacare Holdings
2.12.1 Aspen Pharmacare Holdings Details
2.12.2 Aspen Pharmacare Holdings Major Business
2.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product and Solutions
2.12.4 Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Aspen Pharmacare Holdings Recent Developments and Future Plans
2.13 Ajanta Pharma
2.13.1 Ajanta Pharma Details
2.13.2 Ajanta Pharma Major Business
2.13.3 Ajanta Pharma Artemisinin Combination Therapy Product and Solutions
2.13.4 Ajanta Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ajanta Pharma Recent Developments and Future Plans
2.14 Guilin Pharmaceuticals
2.14.1 Guilin Pharmaceuticals Details
2.14.2 Guilin Pharmaceuticals Major Business
2.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
2.14.4 Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Guilin Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artemisinin Combination Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Artemisinin Combination Therapy by Company Revenue
3.2.2 Top 3 Artemisinin Combination Therapy Players Market Share in 2023
3.2.3 Top 6 Artemisinin Combination Therapy Players Market Share in 2023
3.3 Artemisinin Combination Therapy Market: Overall Company Footprint Analysis
3.3.1 Artemisinin Combination Therapy Market: Region Footprint
3.3.2 Artemisinin Combination Therapy Market: Company Product Type Footprint
3.3.3 Artemisinin Combination Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artemisinin Combination Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Artemisinin Combination Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Artemisinin Combination Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
6.2 North America Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
6.3 North America Artemisinin Combination Therapy Market Size by Country
6.3.1 North America Artemisinin Combination Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
7.2 Europe Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
7.3 Europe Artemisinin Combination Therapy Market Size by Country
7.3.1 Europe Artemisinin Combination Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7.3.3 France Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Region
8.3.1 Asia-Pacific Artemisinin Combination Therapy Consumption Value by Region (2019-2030)
8.3.2 China Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.5 India Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
9.2 South America Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
9.3 South America Artemisinin Combination Therapy Market Size by Country
9.3.1 South America Artemisinin Combination Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artemisinin Combination Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Artemisinin Combination Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Country
10.3.1 Middle East & Africa Artemisinin Combination Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Artemisinin Combination Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Artemisinin Combination Therapy Market Drivers
11.2 Artemisinin Combination Therapy Market Restraints
11.3 Artemisinin Combination Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Artemisinin Combination Therapy Industry Chain
12.2 Artemisinin Combination Therapy Upstream Analysis
12.3 Artemisinin Combination Therapy Midstream Analysis
12.4 Artemisinin Combination Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Artemisinin Combination Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Artemisinin Combination Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Artemisinin Combination Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Artemisinin Combination Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. KPC Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. KPC Pharmaceuticals Major Business
Table 7. KPC Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
Table 8. KPC Pharmaceuticals Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. KPC Pharmaceuticals Recent Developments and Future Plans
Table 10. Shanghai Fosun Pharmaceutical Industrial Development Company Information, Head Office, and Major Competitors
Table 11. Shanghai Fosun Pharmaceutical Industrial Development Major Business
Table 12. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product and Solutions
Table 13. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Shanghai Fosun Pharmaceutical Industrial Development Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Artemisinin Combination Therapy Product and Solutions
Table 18. Sanofi Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Sanofi Recent Developments and Future Plans
Table 20. Desano Holdings Company Information, Head Office, and Major Competitors
Table 21. Desano Holdings Major Business
Table 22. Desano Holdings Artemisinin Combination Therapy Product and Solutions
Table 23. Desano Holdings Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Desano Holdings Recent Developments and Future Plans
Table 25. Calyx Chemicals and Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Calyx Chemicals and Pharmaceuticals Major Business
Table 27. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
Table 28. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Calyx Chemicals and Pharmaceuticals Recent Developments and Future Plans
Table 30. Mylan Company Information, Head Office, and Major Competitors
Table 31. Mylan Major Business
Table 32. Mylan Artemisinin Combination Therapy Product and Solutions
Table 33. Mylan Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Mylan Recent Developments and Future Plans
Table 35. Novartis Company Information, Head Office, and Major Competitors
Table 36. Novartis Major Business
Table 37. Novartis Artemisinin Combination Therapy Product and Solutions
Table 38. Novartis Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Novartis Recent Developments and Future Plans
Table 40. Denk Pharma Company Information, Head Office, and Major Competitors
Table 41. Denk Pharma Major Business
Table 42. Denk Pharma Artemisinin Combination Therapy Product and Solutions
Table 43. Denk Pharma Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Denk Pharma Recent Developments and Future Plans
Table 45. Hovid Berhad Company Information, Head Office, and Major Competitors
Table 46. Hovid Berhad Major Business
Table 47. Hovid Berhad Artemisinin Combination Therapy Product and Solutions
Table 48. Hovid Berhad Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Hovid Berhad Recent Developments and Future Plans
Table 50. Ipca Laboratories Company Information, Head Office, and Major Competitors
Table 51. Ipca Laboratories Major Business
Table 52. Ipca Laboratories Artemisinin Combination Therapy Product and Solutions
Table 53. Ipca Laboratories Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Ipca Laboratories Recent Developments and Future Plans
Table 55. Cipla Company Information, Head Office, and Major Competitors
Table 56. Cipla Major Business
Table 57. Cipla Artemisinin Combination Therapy Product and Solutions
Table 58. Cipla Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Cipla Recent Developments and Future Plans
Table 60. Aspen Pharmacare Holdings Company Information, Head Office, and Major Competitors
Table 61. Aspen Pharmacare Holdings Major Business
Table 62. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product and Solutions
Table 63. Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Aspen Pharmacare Holdings Recent Developments and Future Plans
Table 65. Ajanta Pharma Company Information, Head Office, and Major Competitors
Table 66. Ajanta Pharma Major Business
Table 67. Ajanta Pharma Artemisinin Combination Therapy Product and Solutions
Table 68. Ajanta Pharma Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Ajanta Pharma Recent Developments and Future Plans
Table 70. Guilin Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 71. Guilin Pharmaceuticals Major Business
Table 72. Guilin Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
Table 73. Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Guilin Pharmaceuticals Recent Developments and Future Plans
Table 75. Global Artemisinin Combination Therapy Revenue (USD Million) by Players (2019-2024)
Table 76. Global Artemisinin Combination Therapy Revenue Share by Players (2019-2024)
Table 77. Breakdown of Artemisinin Combination Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Artemisinin Combination Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Artemisinin Combination Therapy Players
Table 80. Artemisinin Combination Therapy Market: Company Product Type Footprint
Table 81. Artemisinin Combination Therapy Market: Company Product Application Footprint
Table 82. Artemisinin Combination Therapy New Market Entrants and Barriers to Market Entry
Table 83. Artemisinin Combination Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Artemisinin Combination Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Artemisinin Combination Therapy Consumption Value Share by Type (2019-2024)
Table 86. Global Artemisinin Combination Therapy Consumption Value Forecast by Type (2025-2030)
Table 87. Global Artemisinin Combination Therapy Consumption Value by Application (2019-2024)
Table 88. Global Artemisinin Combination Therapy Consumption Value Forecast by Application (2025-2030)
Table 89. North America Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Artemisinin Combination Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Artemisinin Combination Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Artemisinin Combination Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Artemisinin Combination Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Artemisinin Combination Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Artemisinin Combination Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Artemisinin Combination Therapy Raw Material
Table 120. Key Suppliers of Artemisinin Combination Therapy Raw Materials
Table 1. Global Artemisinin Combination Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Artemisinin Combination Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Artemisinin Combination Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Artemisinin Combination Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. KPC Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. KPC Pharmaceuticals Major Business
Table 7. KPC Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
Table 8. KPC Pharmaceuticals Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. KPC Pharmaceuticals Recent Developments and Future Plans
Table 10. Shanghai Fosun Pharmaceutical Industrial Development Company Information, Head Office, and Major Competitors
Table 11. Shanghai Fosun Pharmaceutical Industrial Development Major Business
Table 12. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product and Solutions
Table 13. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Shanghai Fosun Pharmaceutical Industrial Development Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Artemisinin Combination Therapy Product and Solutions
Table 18. Sanofi Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Sanofi Recent Developments and Future Plans
Table 20. Desano Holdings Company Information, Head Office, and Major Competitors
Table 21. Desano Holdings Major Business
Table 22. Desano Holdings Artemisinin Combination Therapy Product and Solutions
Table 23. Desano Holdings Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Desano Holdings Recent Developments and Future Plans
Table 25. Calyx Chemicals and Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Calyx Chemicals and Pharmaceuticals Major Business
Table 27. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
Table 28. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Calyx Chemicals and Pharmaceuticals Recent Developments and Future Plans
Table 30. Mylan Company Information, Head Office, and Major Competitors
Table 31. Mylan Major Business
Table 32. Mylan Artemisinin Combination Therapy Product and Solutions
Table 33. Mylan Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Mylan Recent Developments and Future Plans
Table 35. Novartis Company Information, Head Office, and Major Competitors
Table 36. Novartis Major Business
Table 37. Novartis Artemisinin Combination Therapy Product and Solutions
Table 38. Novartis Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Novartis Recent Developments and Future Plans
Table 40. Denk Pharma Company Information, Head Office, and Major Competitors
Table 41. Denk Pharma Major Business
Table 42. Denk Pharma Artemisinin Combination Therapy Product and Solutions
Table 43. Denk Pharma Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Denk Pharma Recent Developments and Future Plans
Table 45. Hovid Berhad Company Information, Head Office, and Major Competitors
Table 46. Hovid Berhad Major Business
Table 47. Hovid Berhad Artemisinin Combination Therapy Product and Solutions
Table 48. Hovid Berhad Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Hovid Berhad Recent Developments and Future Plans
Table 50. Ipca Laboratories Company Information, Head Office, and Major Competitors
Table 51. Ipca Laboratories Major Business
Table 52. Ipca Laboratories Artemisinin Combination Therapy Product and Solutions
Table 53. Ipca Laboratories Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Ipca Laboratories Recent Developments and Future Plans
Table 55. Cipla Company Information, Head Office, and Major Competitors
Table 56. Cipla Major Business
Table 57. Cipla Artemisinin Combination Therapy Product and Solutions
Table 58. Cipla Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Cipla Recent Developments and Future Plans
Table 60. Aspen Pharmacare Holdings Company Information, Head Office, and Major Competitors
Table 61. Aspen Pharmacare Holdings Major Business
Table 62. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product and Solutions
Table 63. Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Aspen Pharmacare Holdings Recent Developments and Future Plans
Table 65. Ajanta Pharma Company Information, Head Office, and Major Competitors
Table 66. Ajanta Pharma Major Business
Table 67. Ajanta Pharma Artemisinin Combination Therapy Product and Solutions
Table 68. Ajanta Pharma Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Ajanta Pharma Recent Developments and Future Plans
Table 70. Guilin Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 71. Guilin Pharmaceuticals Major Business
Table 72. Guilin Pharmaceuticals Artemisinin Combination Therapy Product and Solutions
Table 73. Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Guilin Pharmaceuticals Recent Developments and Future Plans
Table 75. Global Artemisinin Combination Therapy Revenue (USD Million) by Players (2019-2024)
Table 76. Global Artemisinin Combination Therapy Revenue Share by Players (2019-2024)
Table 77. Breakdown of Artemisinin Combination Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Artemisinin Combination Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Artemisinin Combination Therapy Players
Table 80. Artemisinin Combination Therapy Market: Company Product Type Footprint
Table 81. Artemisinin Combination Therapy Market: Company Product Application Footprint
Table 82. Artemisinin Combination Therapy New Market Entrants and Barriers to Market Entry
Table 83. Artemisinin Combination Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Artemisinin Combination Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Artemisinin Combination Therapy Consumption Value Share by Type (2019-2024)
Table 86. Global Artemisinin Combination Therapy Consumption Value Forecast by Type (2025-2030)
Table 87. Global Artemisinin Combination Therapy Consumption Value by Application (2019-2024)
Table 88. Global Artemisinin Combination Therapy Consumption Value Forecast by Application (2025-2030)
Table 89. North America Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Artemisinin Combination Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Artemisinin Combination Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Artemisinin Combination Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Artemisinin Combination Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Artemisinin Combination Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Artemisinin Combination Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Artemisinin Combination Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Artemisinin Combination Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Artemisinin Combination Therapy Raw Material
Table 120. Key Suppliers of Artemisinin Combination Therapy Raw Materials
LIST OF FIGURES
Figure 1. Artemisinin Combination Therapy Picture
Figure 2. Global Artemisinin Combination Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Artemisinin Combination Therapy Consumption Value Market Share by Type in 2023
Figure 4. Artemether+Lumefantrine
Figure 5. Artesunate+Amodiaquine
Figure 6. Dihydroartemisinin+Piperaquine
Figure 7. Artesunate+Mefloquine
Figure 8. Artesunate+Sulfadoxine-Pyrimethamine
Figure 9. Pyronaridine-Artesunate
Figure 10. Other
Figure 11. Global Artemisinin Combination Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 12. Artemisinin Combination Therapy Consumption Value Market Share by Application in 2023
Figure 13. Hospital Picture
Figure 14. Clinic Picture
Figure 15. Other Picture
Figure 16. Global Artemisinin Combination Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Artemisinin Combination Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Artemisinin Combination Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Artemisinin Combination Therapy Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Artemisinin Combination Therapy Consumption Value Market Share by Region in 2023
Figure 21. North America Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Artemisinin Combination Therapy Revenue Share by Players in 2023
Figure 27. Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Artemisinin Combination Therapy Market Share in 2023
Figure 29. Global Top 6 Players Artemisinin Combination Therapy Market Share in 2023
Figure 30. Global Artemisinin Combination Therapy Consumption Value Share by Type (2019-2024)
Figure 31. Global Artemisinin Combination Therapy Market Share Forecast by Type (2025-2030)
Figure 32. Global Artemisinin Combination Therapy Consumption Value Share by Application (2019-2024)
Figure 33. Global Artemisinin Combination Therapy Market Share Forecast by Application (2025-2030)
Figure 34. North America Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Artemisinin Combination Therapy Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Artemisinin Combination Therapy Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 44. France Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Artemisinin Combination Therapy Consumption Value Market Share by Region (2019-2030)
Figure 51. China Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 54. India Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Artemisinin Combination Therapy Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Artemisinin Combination Therapy Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 68. Artemisinin Combination Therapy Market Drivers
Figure 69. Artemisinin Combination Therapy Market Restraints
Figure 70. Artemisinin Combination Therapy Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Artemisinin Combination Therapy in 2023
Figure 73. Manufacturing Process Analysis of Artemisinin Combination Therapy
Figure 74. Artemisinin Combination Therapy Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Artemisinin Combination Therapy Picture
Figure 2. Global Artemisinin Combination Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Artemisinin Combination Therapy Consumption Value Market Share by Type in 2023
Figure 4. Artemether+Lumefantrine
Figure 5. Artesunate+Amodiaquine
Figure 6. Dihydroartemisinin+Piperaquine
Figure 7. Artesunate+Mefloquine
Figure 8. Artesunate+Sulfadoxine-Pyrimethamine
Figure 9. Pyronaridine-Artesunate
Figure 10. Other
Figure 11. Global Artemisinin Combination Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 12. Artemisinin Combination Therapy Consumption Value Market Share by Application in 2023
Figure 13. Hospital Picture
Figure 14. Clinic Picture
Figure 15. Other Picture
Figure 16. Global Artemisinin Combination Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Artemisinin Combination Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Artemisinin Combination Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Artemisinin Combination Therapy Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Artemisinin Combination Therapy Consumption Value Market Share by Region in 2023
Figure 21. North America Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Artemisinin Combination Therapy Revenue Share by Players in 2023
Figure 27. Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Artemisinin Combination Therapy Market Share in 2023
Figure 29. Global Top 6 Players Artemisinin Combination Therapy Market Share in 2023
Figure 30. Global Artemisinin Combination Therapy Consumption Value Share by Type (2019-2024)
Figure 31. Global Artemisinin Combination Therapy Market Share Forecast by Type (2025-2030)
Figure 32. Global Artemisinin Combination Therapy Consumption Value Share by Application (2019-2024)
Figure 33. Global Artemisinin Combination Therapy Market Share Forecast by Application (2025-2030)
Figure 34. North America Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Artemisinin Combination Therapy Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Artemisinin Combination Therapy Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 44. France Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Artemisinin Combination Therapy Consumption Value Market Share by Region (2019-2030)
Figure 51. China Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 54. India Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Artemisinin Combination Therapy Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Artemisinin Combination Therapy Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Artemisinin Combination Therapy Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Artemisinin Combination Therapy Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Artemisinin Combination Therapy Consumption Value (2019-2030) & (USD Million)
Figure 68. Artemisinin Combination Therapy Market Drivers
Figure 69. Artemisinin Combination Therapy Market Restraints
Figure 70. Artemisinin Combination Therapy Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Artemisinin Combination Therapy in 2023
Figure 73. Manufacturing Process Analysis of Artemisinin Combination Therapy
Figure 74. Artemisinin Combination Therapy Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
